CTI BioPharma Statistics
Total Valuation
agilon health has a market cap or net worth of $369.46 million. The enterprise value is $62.24 million.
Important Dates
The last earnings date was Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
agilon health has 414.42 million shares outstanding. The number of shares has increased by 1.34% in one year.
| Current Share Class | 414.42M |
| Shares Outstanding | 414.42M |
| Shares Change (YoY) | +1.34% |
| Shares Change (QoQ) | +0.22% |
| Owned by Insiders (%) | 1.60% |
| Owned by Institutions (%) | 78.78% |
| Float | 307.80M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.06 |
| Forward PS | 0.05 |
| PB Ratio | 0.87 |
| P/TBV Ratio | 1.09 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.01 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.10.
| Current Ratio | 1.16 |
| Quick Ratio | 1.12 |
| Debt / Equity | 0.10 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -59.56 |
Financial Efficiency
Return on equity (ROE) is -60.68% and return on invested capital (ROIC) is -39.90%.
| Return on Equity (ROE) | -60.68% |
| Return on Assets (ROA) | -12.07% |
| Return on Invested Capital (ROIC) | -39.90% |
| Return on Capital Employed (ROCE) | -80.68% |
| Revenue Per Employee | $5.48M |
| Profits Per Employee | -$293,367 |
| Employee Count | 1,076 |
| Asset Turnover | 3.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, agilon health has paid $1.43 million in taxes.
| Income Tax | 1.43M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.85% in the last 52 weeks. The beta is 0.14, so agilon health's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -83.85% |
| 50-Day Moving Average | 2.02 |
| 200-Day Moving Average | 2.84 |
| Relative Strength Index (RSI) | 19.00 |
| Average Volume (20 Days) | 18,917,118 |
Short Selling Information
The latest short interest is 18.92 million, so 4.57% of the outstanding shares have been sold short.
| Short Interest | 18.92M |
| Short Previous Month | 20.84M |
| Short % of Shares Out | 4.57% |
| Short % of Float | 6.15% |
| Short Ratio (days to cover) | 6.66 |
Income Statement
In the last 12 months, agilon health had revenue of $5.90 billion and -$315.66 million in losses. Loss per share was -$0.77.
| Revenue | 5.90B |
| Gross Profit | -104.13M |
| Operating Income | -374.21M |
| Pretax Income | -296.85M |
| Net Income | -315.66M |
| EBITDA | -347.30M |
| EBIT | -374.21M |
| Loss Per Share | -$0.77 |
Full Income StatementBalance Sheet
The company has $327.00 million in cash and $41.37 million in debt, giving a net cash position of $285.63 million or $0.69 per share.
| Cash & Cash Equivalents | 327.00M |
| Total Debt | 41.37M |
| Net Cash | 285.63M |
| Net Cash Per Share | $0.69 |
| Equity (Book Value) | 408.93M |
| Book Value Per Share | 0.99 |
| Working Capital | 203.57M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$58.36 million and capital expenditures -$13.90 million, giving a free cash flow of -$72.26 million.
| Operating Cash Flow | -58.36M |
| Capital Expenditures | -13.90M |
| Free Cash Flow | -72.26M |
| FCF Per Share | -$0.17 |
Full Cash Flow StatementMargins
Gross margin is -1.76%, with operating and profit margins of -6.34% and -5.35%.
| Gross Margin | -1.76% |
| Operating Margin | -6.34% |
| Pretax Margin | -5.55% |
| Profit Margin | -5.35% |
| EBITDA Margin | -5.89% |
| EBIT Margin | -6.34% |
| FCF Margin | n/a |
Dividends & Yields
agilon health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.34% |
| Shareholder Yield | -1.34% |
| Earnings Yield | -90.74% |
| FCF Yield | -20.77% |
Dividend DetailsAnalyst Forecast
The average price target for agilon health is $3.57, which is 300.45% higher than the current price. The consensus rating is "Hold".
| Price Target | $3.57 |
| Price Target Difference | 300.45% |
| Analyst Consensus | Hold |
| Analyst Count | 19 |
| Revenue Growth Forecast (5Y) | 12.17% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
agilon health has an Altman Z-Score of 2.17 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.17 |
| Piotroski F-Score | 2 |
